News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901
Photo taken from Sumanta K. Pal/Twitter
Oct 27, 2023, 04:48

Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901

Sumanta K. Pal, Co-Director of the City of Hope Kidney Cancer Program, posted on Twitter:

“Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901. Loved the fact that she offered a strong, definitive opinion on the “winner” in the battle between these options. Also (not shown) great outline of remaining questions – what comes after EVP? “

Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901

Source: Sumanta K. Pal/Twitter

Andrea Apolo cancer ESMO 2023 National Cancer Institute OncoDaily Oncology Sumanta K. Pal
Special Coverage
Blog
Apr 16, 2025, 19:01
Richard Sullivan: WHO Meeting Reflected on Cancer and IO Drug Pairs
Blog
Apr 16, 2025, 18:50
Join the Third Annual Virtual TAPUR Study Grand Rounds 2025 - ASCO
Blog
Apr 16, 2025, 18:44
The month of the Explore Your Health festival is coming to an end - IARC/WHO
Blog
Apr 16, 2025, 18:38
Why doesn't your body attack the food you eat? - Cancer Research Institute
Blog
Apr 16, 2025, 18:33
Massive Bio has officially received certification from the CNIL
Blog
Apr 16, 2025, 18:17
Peter Pisters: It was wonderful to drop by MD Anderson Cancer Center’s LEADing Leaders/LEADing Institution Training
Blog
Apr 16, 2025, 18:15
MASCC Guidance on Osteoradionecrosis in Patients with Head and Neck Cancer
Blog
Apr 16, 2025, 17:56
Study MSc Transformative Oncology from The University of Manchester online and part-time
Blog
Apr 16, 2025, 17:55
Amol Akhade: Should CDK4/6 inhibitors be standard in early HR+/HER2– breast cancer?
Blog
Apr 16, 2025, 17:46
Dégi László Csaba called for action on QoL in cancer care at EUonQol General Assembly - European Cancer Organisation
Opinion
Apr 16, 2025, 17:39
Is Cancer Hereditary? Myths and Facts about Cancer Genetics
Blog
Apr 16, 2025, 17:37
Are you working on neoadjuvant immunotherapy? - 3P Solution